申请人:GlaxoSmithKline Intellectual Property Development Limited
公开号:US10364254B2
公开(公告)日:2019-07-30
The present invention relates to novel compounds or pharmaceutically acceptable salts thereof, corresponding pharmaceutical compositions and treatment methods or uses as antibacterials for bacterial infections.
本发明涉及作为细菌感染抗菌剂的新型化合物或其药学上可接受的盐、相应的药物组合物和治疗方法或用途。